Pregnancy-associated plasma proteins and Stanniocalcin-2 - Novel players controlling IGF-I physiology.

Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society
Jan FrystykRikke Hjortebjerg

Abstract

IGF-I was originally discovered as a GH-dependent growth factor stimulating longitudinal growth. Currently, however, it has become evident that the biological activities of IGF-I extend well beyond those of a simple growth factor and impact such processes as insulin sensitivity, aging, cancer and cardiovascular disease. The vast majority of IGF-I is tightly bound to IGF-binding proteins (IGFBPs), which renders IGF-I unable to stimulate the IGF-I receptor (IGF-IR) in vivo. This binding means that liberation of IGF-I from the IGFBPs is an important step controlling IGF-I action. In this context, IGFBP-cleaving enzymes appear to play a key role. Enzymatic cleavage of the IGFBPs markedly lowers their ligand affinity, and as a consequence, IGF-I becomes liberated and hence available for stimulation of the IGF-IR. Two of the best-characterized IGFBP-cleaving enzymes are pregnancy-associated plasma protein-A (PAPP-A) and its paralog PAPP-A2. The two enzymes (often referred to as pappalysins) regulate the liberation of IGF-I in a highly controlled manner. PAPP-A is believed to act predominantly in tissues, serving to liberate IGF-I at the cell surface in close proximity to the IGF-IR. In keeping with this notion, mice lacking PAPP-A ex...Continue Reading

References

May 15, 1978·FEBS Letters·E Rinderknecht, R E Humbel
Oct 1, 1990·The Journal of Clinical Endocrinology and Metabolism·P HossenloppM Binoux
Dec 1, 1986·The Journal of Clinical Investigation·R C Baxter, J L Martin
Jul 16, 1987·The New England Journal of Medicine·H P GulerE R Froesch
Oct 1, 1984·Acta Endocrinologica·M BäckströmV Sara
Mar 17, 1999·Proceedings of the National Academy of Sciences of the United States of America·J B LawrenceC A Conover
Feb 13, 2001·Endocrine Reviews·D Le RoithA Butler
Dec 6, 2002·Endocrine Reviews·Sue M Firth, Robert C Baxter
Feb 27, 2003·American Journal of Physiology. Endocrinology and Metabolism·Jian-Wen ChenJan Frystyk
Sep 16, 2004·American Journal of Physiology. Endocrinology and Metabolism·Anthony D GagliardiGabriel E DiMattia
Oct 29, 2004·The Journal of Clinical Endocrinology and Metabolism·Jian-Wen ChenJan Frystyk
Nov 4, 2004·The Journal of Clinical Endocrinology and Metabolism·Helena K GleesonStephen M Shalet
Aug 8, 2007·Aging Cell·Cheryl A Conover, Laurie K Bale
Feb 9, 2008·Endocrinology·Andy C-M ChangRoger R Reddel
May 28, 2009·The Journal of Clinical Endocrinology and Metabolism·J FrystykK K Miller
Sep 3, 2009·Molecular and Cellular Endocrinology·Michael Højby Rasmussen
Sep 23, 2009·Clinical Endocrinology·Nilani JeyaratnaganthanJan Frystyk
Oct 23, 2009·The Journal of Clinical Endocrinology and Metabolism·Ayman M ArafatAndreas F H Pfeiffer
Apr 17, 2010·Science·Luigi FontanaValter D Longo
Jul 30, 2010·The Journal of Clinical Endocrinology and Metabolism·Pouneh K FazeliAnne Klibanski
Nov 26, 2011·Molecular and Cellular Endocrinology·B H Y YeungChris K C Wong
Dec 14, 2011·Domestic Animal Endocrinology·J Frystyk
Apr 3, 2012·Trends in Endocrinology and Metabolism : TEM·Cheryl A Conover
Jun 12, 2012·Endocrinology and Metabolism Clinics of North America·David R Clemmons
Nov 23, 2013·Expert Opinion on Therapeutic Targets·Rikke HjortebjergJan Frystyk
Nov 28, 2013·Best Practice & Research. Clinical Endocrinology & Metabolism·Rikke Hjortebjerg, Jan Frystyk
Apr 12, 2014·Nature Reviews. Cancer·Robert C Baxter
May 13, 2014·Experimental Gerontology·Sara L Harstad, Cheryl A Conover
Dec 23, 2014·The Journal of Clinical Endocrinology and Metabolism·Jesper S SorensenUNKNOWN Danish Society for Diabetes in Childhood and Adolescence
Dec 24, 2014·The Journal of Biological Chemistry·Malene R JepsenClaus Oxvig
Jan 27, 2015·Journal of Cell Communication and Signaling·Claus Oxvig
Nov 3, 2015·Best Practice & Research. Clinical Endocrinology & Metabolism·Andreas Hoeflich, Vincenzo C Russo

❮ Previous
Next ❯

Citations

Sep 3, 2020·The Journal of Clinical Endocrinology and Metabolism·Rikke HjortebjergJo G R De Mey

❮ Previous
Next ❯

Related Concepts

Related Feeds

Aging-Associated Metabolic Disorders

Age is associated with many metabolic disorders including cardiovascular diseases, type 2 diabetes, stroke and heart disease. The mediators in aging process have been suggested to play a part in the cellular processes responsible for these metabolic disorders. Here is the latest research on aging-associated metabolic disorders.